Long term follow up by a coordinating physiotherapist
BehavioralMonthly meetings with an coordinating physiotherapist who motivate and encourage the patient to do 60 minutes of weekly exercise and 30 minutes of daily physical activity
NCT Number: NCT01467206
The LAST study is a Norwegian multi site randomised controlled trial that intends to assess the effect of a long term follow up program after stroke. The program consists of a coordinating physiotherapist who will encourage and motivate included patients to perform at least 60 minutes of intensive motor training every week and 30 minutes of physical activity every day for 18 months after inclusion. The primary hypothesis is that patients receiving a long term follow up program after stroke will have better motor function at end of follow up than patients receiving standard care. A total of 390 home dwelling stroke patients living in the municipality of Trondheim, Asker and Bærum will be included at the out-patient clinic at St. Olavs Hospital or Bærum Hospital three months after their stroke. Included patients will be randomised to an intervention group receiving the long term follow up program or to a control group receiving standard care. Motor function, mental health and physical functioning in daily life will be assessed at inclusion and 18 months later. The LAST study is funded by the Norwegian Research Council, the Norwegian University of Science and Technology and the Central Norway Regional Health Authority and will conclude at the end of 2015.
Looking for future studies?
Notify Me18 year–95 year
All sexes
Interventional
Not applicable
Bærum Hospital, Sandvika, Norway
Supplement to the Life After Stroke - the LAST study ClinicalTrials.gov ID: NCT01467206
Changes in the planned statistical analysis, November 9, 2015 The original plan for statistical analysis was published in; Askim T, Langhammer B, Ihle-Hansen H, Magnussen J, Engstad T, Indredavik B. A Long-Term Follow-Up Programme for Maintenance of Motor Function after Stroke: Protocol of the life after Stroke-The LAST Study. Stroke Res Treat. 2012;2012:392101. doi: 10.1155/2012/392101. Epub 2012 Nov 22.
Original plan for statistical analysis Reporting will follow the CONSORT statement for parallel group randomized trials [40]. Descriptive statistics will be performed in order to present the population and the characteristic of the two groups. All analyses will be analysed as intention-to-treat analysis according to the CONSORT instructions. Analysis of covariance (ANCOVA) will be used to study differences between groups according to the primary endpoint, motor assessment scale at 18 months after inclusion. The ANCOVA model will include stroke severity, age, pre stroke disability, treatment group, and motor function at baseline as covariates. Mann-Whitney U test will be used for secondary data not being normal distributed. In all analyses we will control for potential confounding factors, investigate effect modifications, and present both unadjusted and adjusted effects with 95% confidence intervals.
Subanalysis will be performed according to the stratification variables (stroke severity, age above 80 and recruitment site) to explore trends within subgroups of patients.
Revised plan for statistical analysis Reporting will follow the CONSORT statement for parallel group randomized trials [40]. Descriptive statistics will be performed in order to present the population and the characteristic of the two groups. All analyses will be analysed as intention-to-treat analysis according to the CONSORT instructions. Analysis of covariance (ANCOVA) will be used to study differences between groups according to the primary endpoint, motor assessment scale at 18 months after inclusion. The ANCOVA model will include stroke severity, age, pre stroke disability, treatment group, and motor function at baseline as covariates. Similar ANCOVA analyses will be used for the relevant secondary endpoints. Mann-Whitney U test will be used for secondary data not being normal distributed.
Subanalysis will be performed according to the stratification variables (stroke severity, age above 80 and recruitment site), gender, and cognitive status (Mini Mental State below 25), to explore trends within subgroups of patients.
Missing values will be handled using single imputation (typically for items on instrument scales), or by multiple imputation, as appropriate.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Monthly meetings with an coordinating physiotherapist who motivate and encourage the patient to do 60 minutes of weekly exercise and 30 minutes of daily physical activity
Standard care as it is given to all stoke patients after stroke
Time frame: 18 months after inclusion
A measure of over all motor function
Time frame: 18 months follow up
A measure of activities of daily living
Time frame: 18 months follow up
A measure of dependency/independency
Time frame: 18 months follow up
A measure of balance related to basic movement tasks
Time frame: 18 months follow up
A measure of balance related to transfer and walking
Time frame: 18 months follow up
A measure of dynamic muscle strength according to a sit to stand task
Time frame: 18 months follow up
A measure of endurance
Time frame: 18 months follow up
A measure of health related quality of life after stroke
Time frame: 18 months follow up
A simple measure of health related quality of life for the general population
Time frame: 18 months follow up
A measure of the presence of fatigue
Time frame: 18 months follow up
A simple question used to assess tiredness in teh general Norwegian population
Time frame: 18 months follow up
A measure of anxiety and depression
Time frame: 18 months follow up
A measure of cognitive function
Time frame: 18 months follow up
A measure of cognitive function related to vascular dementia
Time frame: 6, 12 and 18 months
Serious falls will be recorded from the patients hospital records
Time frame: 6, 12 and 18 months
Number of readmissions to hospital will be recorded from the patients medical records
Time frame: 6, 12 and 18 months
Information about death will be collected from the Norwegain Death Registry
Time frame: 6, 12 and 18 months
Information about fractures during follow up will be collected from the patients medical records
Time frame: 6, 12 and 18 months
Information about any cardiovascular events will be collected from the patients medical record
Time frame: 6, 12 and 18 months
Information about any cerebrovascular events during follow up will be collected from teh patient's medical records
Time frame: 6, 12 and 18 months
A measure of physical activity over the last week
Time frame: 6, 12 and 18 months
A sensor system to assess the amount of physical activity during a 4-7 day period
Time frame: 18 months
A simple measure of physical activity
Time frame: 6, 12 and 18 months
Information about the use of health services will be collected by reviewing the patients' hospital records and records in primary health care system.
Time frame: 18 months follow up
A measure of stroke severity
Time frame: 18 months follow up
A measure to rate the degree of spasticity after stroke
Time frame: 18 months follow up
A simple measure of maximum gait speed across a 10 metres distance
Time frame: 18 months follow up
A simple measure of executive cognitive function
Time frame: 18 months follow up
A standard assessment of negative affectivity, social inhibition, and type D personality, which might be related to poor cardiovascular prognosis.
Time frame: 18 months follow up
VO2-peak is obtained by use of a symptom limited treadmill test to measure cardiovascular fitness.
This measure is only used in the Trondheim arm of the study
Norwegian University of Science and Technology
Other
Life After STroke - the LAST Study. A Norwegian Multi Centre Randomized Controlled Trial
Acronym: LAST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03148340
Brain Diseases, Brain Infarction
Jacksonville, Florida, United States
View Trial DetailsNCT03177161
Brain Diseases, Brain Infarction
Ystrad Mynach, Caerphilly, United Kingdom
View Trial DetailsNCT03086863
Arthralgia, Brain Diseases
Seoul, South Korea
View Trial DetailsNCT02795052
ALS, Alzheimer Disease
Westport, Connecticut, United States
View Trial Details